Recent Advances in Molecular Cancer Therapeutics
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 308
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue focuses on recent advances in molecular cancer therapeutics, especially new anticancer drug discovery and development. The article may be either a full paper or a communication based on your research in molecular cancer therapeutics or may be a focused review article on some aspect of the subject. Potential topics include but are not limited to the following research areas:
- Anticancer drug discovery and development
- Cancer metabolism
- Cancer inflammatory microenvironment
- Cancer biomarkers
- Cancer therapy
- The discovery and preclinical development of novel therapeutic agents for oncology
- Preclinical studies of approved therapeutics
- Mechanisms of drug action
- Mechanisms of drug resistance
- Biomarkers of drug response
- Novel models and technologies
- Occasional drug toxicity mechanisms
Dr. Alok Ranjan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Anticancer drug discovery and development
- Cancer metabolism
- Cancer inflammatory microenvironment
- Cancer biomarkers
- Cancer therapy
- The discovery and preclinical development of novel therapeutic agents for oncology
- Preclinical studies of approved therapeutics
- Mechanisms of drug action
- Mechanisms of drug resistance
- Biomarkers of drug response
- Novel models and technologies
- Occasional drug toxicity mechanisms
